Results 61 to 70 of about 3,933,383 (301)

Ages for exoplanet host stars

, 2018
Age is an important characteristic of a planetary system, but also one that is difficult to determine. Assuming that the host star and the planets are formed at the same time, the challenge is to determine the stellar age.
A Claret, A Fogtmann-Schulz, A Skumanich, AHMJ Triaud, AJ Burgasser, AM Serenelli, Andrew W. Mann, Andrew W. Mann, Andrew W. Mann, Andrew W. Mann, B Durney, BR Jørgensen, CP Folsom, CP Folsom, D Huber, D Segransan, DR Soderblom, DR Soderblom, E Sandford, EE Mamajek, F Pont, FR Chromey, G Somers, Gaia Collaboration, Brown AGA, Vallenari A et al, H Rauer, JL Saders van, JN Connelly, K Zwintz, L Casagrande, M Asplund, M Gillon, MJ Thompson, P Sestito, PFL Maxted, PFL Maxted, R Hanbury Brown, R.D. Jeffries, RS Booth, Rudolf Kippenhahn, S Basu, S Deheuvels, S Meibom, S Meibom, S Meibom, S Meibom, SA Barnes, SA Barnes, SA Barnes, T. L. Campante, Tabetha S. Boyajian, TD Brandt, TM Brown, TR White, V Silva Aguirre, V Silva Aguirre   +54 more
core   +1 more source

Adherence to Protocol Recommendations for Children With Wilms Tumour in Two Consecutive Studies in the United Kingdom and Ireland—Does Variation Matter?

Pediatric Blood &Cancer, EarlyView.
ABSTRACT Background and Aims Wilms tumour (WT) has excellent event‐free and overall survival (OS). However, small differences exist between countries participating in the same international study. This led us to examine variation in adherence to protocol recommendations as a potential contributing factor.
Suzanne Tugnait, R. Al‐Saadi, A. Lopez‐Cortes, K. Dzhuma, M. Oostveen, J. Brok, S. Irtan, M. Weeks, J. Bate, S. Baker, R. Williams, M. Powis, D. Saunders, O. Olsen, T. Watson, S. Shelmerdine, S. Vaidya, L. Howell, C. Duncan, G. M. Vujanic, C. Stiller, G. P. Balchin, T. Chowdhury, K. Pritchard‐Jones   +23 more
wiley   +1 more source

RELATO DE CASO: DESAFIOS PARA O DIAGNÓSTICO DE LINFOMA DE CÉLULAS DO MANTO

Hematology, Transfusion and Cell Therapy
Introdução: O Linfoma de Células do Manto (LCM) é um tipo de câncer hematológico raro e agressivo que afeta os linfócitos B maduros. Representa cerca de 6% dos linfomas não-Hodgkin, com maior incidência em homens acima de 60 anos.
MS Santos, AM Lima, AB Macêdo, LNS Oliveira, LD Silva, OF Oliveira, PFN Queiroga, BR Sampaio, RL Costa, EMM Costa   +9 more
doaj   +1 more source

AGEs-Induced Calcification and Apoptosis in Human Vascular Smooth Muscle Cells Is Reversed by Inhibition of Autophagy

Frontiers in Pharmacology, 2021
Vascular calcification (VC) in macrovascular and peripheral blood vessels is one of the main factors leading to diabetes mellitus (DM) and death. Apart from the induction of vascular calcification, advanced glycation end products (AGEs) have also been ...
Hu-Qiang He, Hu-Qiang He, Yuan-Qing Qu, Betty Yuen Kwan Law, Betty Yuen Kwan Law, Cong-ling Qiu, Yu Han, Ivo Ricardo de Seabra Rodrigues Dias, Yong Liu, Jie Zhang, Jie Zhang, An-Guo Wu, An-Guo Wu, Cheng-Wen Wu, Simon Wing Fai Mok, Xin Cheng, Xin Cheng, Yan-Zheng He, Vincent Kam Wai Wong, Vincent Kam Wai Wong   +19 more
doaj   +1 more source

Coarse spaces over the ages

, 2010
The objective of this paper is to explain the principles of the design of a coarse space in a simplified way and by pictures. The focus is on ideas rather than on a more historically complete presentation.
Mandel, Jan, Sousedík, Bedřich
core   +1 more source

Sirolimus for Extracranial Arteriovenous Malformations: A Scoping Review of the Evidence in Syndromic and Non‐Syndromic Cases

Pediatric Blood &Cancer, EarlyView.
ABSTRACT Arteriovenous malformations (AVMs) are rare, high‐flow, vascular anomalies that can occur either sporadically or as part of a genetic syndrome. AVMs can progress with serious morbidity and even mortality if left unchecked. Sirolimus is an mTOR inhibitor that is effective in low‐flow vascular malformations; however, its role in AVMs is unclear.
Will Swansson, Ingrid Winship, Gary Hammerschlag, Laura Scardamaglia   +3 more
wiley   +1 more source

RELATO DE CASO: OS DESAFIOS NA TERAPÊUTICA DA LEUCEMIA LINFOCÍTICA CRÔNICA, EM PACIENTES COM DOENÇAS AUTOIMUNES NÃO HEMATOLÓGICAS ASSOCIADAS

Hematology, Transfusion and Cell Therapy
Introdução: A Leucemia Linfocítica Crônica (LLC) é uma neoplasia maligna caracterizada pela proliferação clonal de células B maduras CD5+. Nos Estados Unidos, corresponde a 25% das leucemias, enquanto no Brasil não há uma estimativa precisa sobre a sua ...
JFS Neto, AM Lima, MS Santos, WML Gaya, DDR Magnavita, LP Silva, FCC Abreu, MM Rocha, IO Cordeiro, EMM Costa   +9 more
doaj   +1 more source

Differential effects of glycation on protein aggregation and amyloid formation

Frontiers in Molecular Biosciences, 2014
Amyloids are a class of insoluble proteinaceous substances generally composed of linear un-branched fibrils that are formed from misfolded proteins.
Clara eIannuzzi, Gaetano eIrace, Ivana eSirangelo   +2 more
doaj   +1 more source

Evaluating the Utility of Paired Tumor and Germline Targeted DNA Sequencing for Pediatric Oncology Patients: A Single Institution Report

Pediatric Blood &Cancer, EarlyView.
ABSTRACT Objective To evaluate the diagnostic yield and utility of universal paired tumor–normal multigene panel sequencing in newly diagnosed pediatric solid and central nervous system (CNS) tumor patients and to compare the detection of germline pathogenic/likely pathogenic variants (PV/LPVs) against established clinical referral criteria for cancer ...
Natalie Waligorski, Rebecca Ronsley, Shannon M. Stasi, Jeffrey Stevens, Erin R. Rudzinski, Christina M. Lockwood, Sarah E. S. Leary, Bonnie L. Cole, Michelle A. Ting, Vera Paulson   +9 more
wiley   +1 more source

Preferences of Pediatric Patients and Their Caregivers for Chemotherapy‐Induced Nausea and Vomiting Control Endpoints: A Mixed Methods Study

Pediatric Blood &Cancer, EarlyView.
ABSTRACT Purpose Although not always achieved, complete chemotherapy‐induced nausea and vomiting (CINV) control is the conventional goal of CINV prophylaxis. In this two‐center, mixed‐methods study, we sought to understand the preferences of adolescent patients and family caregivers for CINV control endpoints.
Haley Newman, Tadi Hondonga, Alison Berry, Caitlin Elgarten, Jason Freedman, Katelyn Oranges, Sara McDonough, Caroline Diorio, L. Lee Dupuis   +8 more
wiley   +1 more source